Cargando…
Safety analysis of German real-life cohort WIP shows rates of neuropsychiatric events leading to discontinuation of raltegravir therapy below 2%
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535805/ https://www.ncbi.nlm.nih.gov/pubmed/31112487 http://dx.doi.org/10.1177/0956462418812642 |
| _version_ | 1783421636590960640 |
|---|---|
| author | Naumann, U Moll, A Schleehauf, D Lutz, KT Schmidt, W Jaeger, H Funke, B Witte, V |
| author_facet | Naumann, U Moll, A Schleehauf, D Lutz, KT Schmidt, W Jaeger, H Funke, B Witte, V |
| author_sort | Naumann, U |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6535805 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | SAGE Publications |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-65358052019-06-25 Safety analysis of German real-life cohort WIP shows rates of neuropsychiatric events leading to discontinuation of raltegravir therapy below 2% Naumann, U Moll, A Schleehauf, D Lutz, KT Schmidt, W Jaeger, H Funke, B Witte, V Int J STD AIDS Letter to the Editor SAGE Publications 2019-05-21 2019-06 /pmc/articles/PMC6535805/ /pubmed/31112487 http://dx.doi.org/10.1177/0956462418812642 Text en © The Author(s) 2018 http://creativecommons.org/licenses/by/4.0/ Creative Commons CC BY: This article is distributed under the terms of the Creative Commons Attribution 4.0 License (http://www.creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
| spellingShingle | Letter to the Editor Naumann, U Moll, A Schleehauf, D Lutz, KT Schmidt, W Jaeger, H Funke, B Witte, V Safety analysis of German real-life cohort WIP shows rates of neuropsychiatric events leading to discontinuation of raltegravir therapy below 2% |
| title | Safety analysis of German real-life cohort WIP shows rates of neuropsychiatric events leading to discontinuation of raltegravir therapy below 2% |
| title_full | Safety analysis of German real-life cohort WIP shows rates of neuropsychiatric events leading to discontinuation of raltegravir therapy below 2% |
| title_fullStr | Safety analysis of German real-life cohort WIP shows rates of neuropsychiatric events leading to discontinuation of raltegravir therapy below 2% |
| title_full_unstemmed | Safety analysis of German real-life cohort WIP shows rates of neuropsychiatric events leading to discontinuation of raltegravir therapy below 2% |
| title_short | Safety analysis of German real-life cohort WIP shows rates of neuropsychiatric events leading to discontinuation of raltegravir therapy below 2% |
| title_sort | safety analysis of german real-life cohort wip shows rates of neuropsychiatric events leading to discontinuation of raltegravir therapy below 2% |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535805/ https://www.ncbi.nlm.nih.gov/pubmed/31112487 http://dx.doi.org/10.1177/0956462418812642 |
| work_keys_str_mv | AT naumannu safetyanalysisofgermanreallifecohortwipshowsratesofneuropsychiatriceventsleadingtodiscontinuationofraltegravirtherapybelow2 AT molla safetyanalysisofgermanreallifecohortwipshowsratesofneuropsychiatriceventsleadingtodiscontinuationofraltegravirtherapybelow2 AT schleehaufd safetyanalysisofgermanreallifecohortwipshowsratesofneuropsychiatriceventsleadingtodiscontinuationofraltegravirtherapybelow2 AT lutzkt safetyanalysisofgermanreallifecohortwipshowsratesofneuropsychiatriceventsleadingtodiscontinuationofraltegravirtherapybelow2 AT schmidtw safetyanalysisofgermanreallifecohortwipshowsratesofneuropsychiatriceventsleadingtodiscontinuationofraltegravirtherapybelow2 AT jaegerh safetyanalysisofgermanreallifecohortwipshowsratesofneuropsychiatriceventsleadingtodiscontinuationofraltegravirtherapybelow2 AT funkeb safetyanalysisofgermanreallifecohortwipshowsratesofneuropsychiatriceventsleadingtodiscontinuationofraltegravirtherapybelow2 AT wittev safetyanalysisofgermanreallifecohortwipshowsratesofneuropsychiatriceventsleadingtodiscontinuationofraltegravirtherapybelow2 |